Immune Checkpoint Inhibitors
Concept
Vocabulary Service
Overview
subject area of
-
A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies Journal Articles
-
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner Journal Articles
-
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer Journal Articles
-
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma Journal Articles
-
Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma Journal Articles
-
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade Journal Articles
-
Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review Journal Articles
-
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer Journal Articles
-
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer Journal Articles
-
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer Journal Articles
-
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors Journal Articles
-
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors Journal Articles
-
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies Journal Articles
-
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Journal Articles
-
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer Journal Articles
-
Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy Journal Articles
-
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells Journal Articles
-
Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition Journal Articles
-
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer Journal Articles
-
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer Journal Articles
-
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review Journal Articles
-
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy Journal Articles
-
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response Journal Articles
-
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Journal Articles
-
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer Journal Articles
-
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer Journal Articles
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors Journal Articles
-
Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers Journal Articles
-
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer Journal Articles
-
The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review Journal Articles
-
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline Journal Articles
-
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis Journal Articles
-
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers Journal Articles